In the UK, obesity-related conditions are estimated to cost the NHS billions each year 2,3,4
According to the Summaries of Product Characteristics (SmPCs), nausea is very common with most GLP-1 medications, while abdominal distension, eructation (belching), and flatulence are typically classified as common side effects, though frequencies differ between products
The companys expansion into biosimilars products that are already legally available as alternatives to branded biologics extends this indirect pressure to biologic drugs that remain under patent protection, because the reference biologic and the biosimilar share a patient population
List of Key Companies Shandong Jincheng Biological Pharmaceutical Kaiping Genuine Biochemical Pharmaceutical Cayman Chemical Company Meteoric Biopharmaceuticals Herbo Nutra YAOPHARMA Kyowa Hakko Bio Anhui GSH Bio-Technology KOHJIN Life Sciences Xian Fengzu Biological Technology Others Key Target Audience Market Players Investors End-users Government Authorities Consulting and Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Developments In April 2025, ProRx Pharma launched four new injectables in its health and wellness product line: Sermorelin, NAD+, Glutathione, and MIC/B6/B12
